Clinical Trials - March 9, 2026
Oncopeptides secures fast-track designation for Window-of-Opportunity study
Oncopeptides has achieved key regulatory agreement with both the Swedish and Norwegian Medical Products Agencies regarding the design of its planned “Window-of-Opportunity” study evaluating a Peptide Drug Conjugate (PDC) in glioblastoma.
Business article - March 7, 2026
Women’s health: 4 x Nordic efforts
The last two years include a new regional policy charter and dedicated Nordic women's health innovation hub introduced in our region.
In a new job - March 6, 2026
Coloplast appoints new CEO
Gavin Wood has been appointed new President and Chief Executive Officer (CEO) of the Coloplast Group, effective May 1, 2026.
Business article - March 6, 2026
Orexo changes the organizational structure and management team
The changes are a result of the divestment of Zubsolv in the US market and focus on advancing development programs and the AmorphOX technology.
Acquisition - March 6, 2026
Sectra acquires Oxipit
Sectra has entered into an agreement to acquire Oxipit, a Lithuanian company specializing in AI-based solutions for radiology.
In a new job - March 5, 2026
She is the new CEO of Innovation District Copenhagen
Annemarie Munk Riis’ background combines leadership roles at Innovation Fund Denmark and The City of Copenhagen with strategic positions at The Danish Ministry of Industry, Business and Financial Affairs.
